European Commission takes steps towards nanotech standards mandate
This article was originally published in Clinica
The European Commission is taking steps to develop a "programming mandate" for standards needed in the areas of nanotechnology and nanoscience, including nanomedtech products. This is a first step in surveying the field to establish exactly what kind of issues need to be addressed and what types of standards are needed.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.